Skip to main content
JD Health International Inc. logo

JD Health International Inc. — Investor Relations & Filings

Ticker · 6618 ISIN · KYG5074A1004 LEI · 254900OM3MAXYK8PCC84 HKEX Human health and social work activities
Open in API
Filings indexed 315 across all filing types
Latest filing 2026-06-05 Transaction in Own Shar…
Country KY Cayman Islands
Listing HKEX 6618

About JD Health International Inc.

https://ir.jdhealth.com

JD Health International Inc. is the largest online healthcare platform and retail pharmacy in China by revenue, operating as the healthcare arm of JD.com. The company drives the digitalization of healthcare by offering a comprehensive suite of digital health services. Its core business includes medical and health e-commerce, internet-based medical services (Internet Hospital), and intelligent hospital solutions. Key offerings span online medical consultations, pharmaceutical retail (prescription and OTC), health check-ups, doctor referrals, genetic testing, and beauty care services, providing consumers with an accessible platform for integrated healthcare needs.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 86% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) detailing movements in JD Health International’s issued shares and treasury shares – including the issue of 300,000 shares under a share award scheme, multiple share repurchases (on-market buybacks), and confirmation of treasury share sales. This is precisely the type of regulatory announcement reporting transactions in the company’s own shares. It does not present financial statements or a broader capital report, nor is it merely a publication notice. Therefore, it falls under the “Transaction in Own Shares” category.
2026-06-05 English
Proxy Form for use at the Annual General Meeting to be held on June 29, 2026
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a proxy form to be used by shareholders at the company’s Annual General Meeting, providing voting instructions and soliciting proxies. It does not contain financial statements or results, nor is it a report publication announcement. It clearly falls under the category of materials sent to shareholders to request votes (Proxy Solicitation & Information Statement).
2026-06-05 English
NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 85% confidence The document is a formal notice convening the Annual General Meeting of JD Health International Inc. It outlines meeting details, ordinary and special resolutions for shareholder approval, and proxy voting instructions. This type of shareholder circular material requesting votes and providing meeting information fits the definition of a Proxy Solicitation & Information Statement rather than a full AGM presentation, annual report, or simple regulatory announcement.
2026-06-05 English
(1) PROPOSED GRANTING OF GENERAL MANDATES TO ISSUE AND REPURCHASE SHARES (2) PROPOSED RE-ELECTION OF RETIRING DIRECTORS (3) PROPOSED RE-APPOINTMENT OF AUDITOR AND (4) NOTICE OF ANNUAL GENERAL MEETING
Proxy Solicitation & Information Statement Classification · 97% confidence The document is a shareholder circular (“circular”) issued by JD Health International Inc. providing detailed proposals for an upcoming Annual General Meeting: granting share issue/repurchase mandates, re-election of directors, re-appointment of auditor, and including the formal notice of AGM and proxy form. It is a solicitation of votes and informational statement for shareholders regarding meeting resolutions rather than the meeting minutes or financial report itself. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2026-06-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2026
Share Issue/Capital Change Classification · 84% confidence The document is a standardized HKEX Listing Rule FF301 monthly return detailing movements in authorized and issued share capital, share options, repurchases, and public float confirmation. It is not an earnings release, management discussion, or annual/interim report but a regulatory submission on share capital changes. This best matches “Share Issue/Capital Change” (SHA).
2026-06-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 91% confidence The document is a Next Day Disclosure Return (Form FF305) filed under Hong Kong Listing Rules detailing share repurchases (on‐market buybacks) and changes in issued and treasury shares by JD Health International Inc. This is a report of transactions in the company’s own shares. Therefore, it fits the “Transaction in Own Shares” category.
2026-05-28 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.